News Center Events Publications

BGI Participates in World's Most Comprehensive Genome Program in Abu Dhabi

On December 10th in the UAE, His Excellency Sheikh Abdulla Bin Mohamed Al Hamed, chairman of the Department of Health – Abu Dhabi, officially announced the launch of the world's most comprehensive genomics program, which will use BGI’s sequencing technology. The ground-breaking population Genome Program aims to use large-scale genomic data to build an innovative healthcare system with predictive, preventive and personalized treatments.

"Million Microbiome of Humans Project“ Will Provide Important Basis for Analyzing the Relationship between Microbiome and Human Health

In October this year, the "Million Microbiome of Humans Project“ (MMHP) was officially launched at the 14th International Conference on Genomics (ICG-14) in Shenzhen. At that time, we interviewed key representatives of the project, including Lars Engstrand, professor at the Center for Microbial Translational Research at the Karolinska Institutet and Liu Ruixin, researcher at the Shanghai National Clinical Research Center for Metabolic Diseases. Recently, MGI officially opened a new R&D and manufacturing facility in Riga, Latvia, aiming to build a bridge between China and Europe for health science innovation. MMHP as a key component is also planning to conduct research work in the facility. We will combine the contents of the speeches and interviews in the two activities to further understand the "Million Microbiome of Humans Project“ (MMHP).

The "Beijing Consensus on High-throughput Sequencing" was officially published

Based on domestic and foreign relevant guidelines, standards, specifications, and expert consensus and the current status of clinical application of high-throughput sequencing technology, Beijing Clinical Laboratory Center and Beijing Medical Association Laboratory Medicine Branch led the organizations to draft the "The Beijing Expert Consensus for the Standardized Application of Technical Clinical Detection"

Interview with Dr. Gong Mengchun | Gene sequencing is a technology with strong clinical availability and broad development prospects

Recently, MGI interviewed Dr. Gong Mengchun, a member of the diagnostic science committee of the International Rare Disease Research Alliance (IRDiRC). He graduated from the Peking Union Medical College School of Clinical Medicine and has extensively participated in the registration of rare diseases, medical informatics research, health care national and international collaborative work on big data standardization.
4000-966-988Hot Line

Wechat Wechat